DMT310-009 Topical in the Treatment of Acne Vulgaris

NCT06090721 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

520

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: DMT310
DRUG: Placebo

Sponsor

Dermata Therapeutics